4SC at ASCO: 4SC-202 and checkpoint inhibitors - strong partners in cancer treatment
4SC AG (4SC, FSE Prime Standard: VSC) will present new research data at ASCO 2016 for its cancer compound 4SC-202. Curre…
4SC AG (4SC, FSE Prime Standard: VSC) will present new research data at ASCO 2016 for its cancer compound 4SC-202. Curre…
Die 4SC AG (4SC, FWB Prime Standard: VSC) präsentiert auf der ASCO 2016 neue wissenschaftliche Daten zum Krebswirkstoff…
Daily dosage of oral, anti-mitotic Eg5 inhibitor shows good safety and tolerability. Specifically, no peripheral neuropa…
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for cancer…
Das Biotechnologie-Unternehmen 4SC AG (Frankfurt, Prime Standard: VSC), das zielgerichtete, niedermolekulare Medikamente…
Das Biotechnologie-Unternehmen 4SC AG (Frankfurt, Prime Standard: VSC), das sich auf die Erforschung und Entwicklung von…
4SC (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indicati…